ACTION

🔥Hot off the press🔥 Happy to share our new paper “Transcatheter ViV for bioprosthetic aortic and mitral SVD - an update”. Nice collaboration with @MGalloMD @DoulamisIlias @Nabil_Hussein_ @PNKampaktsis @PaulaTagliari @Pielaf19 and Prof. Enrico Ferrari tandfonline.com/doi/full/10.10…

Check our results presented in #ACC21 #ACC2021 ✅State-of-the-art ML models created and validated using the @UNOSNews database showed improved accuracy in predicting 1-year mortality after HT. ➡️abstractsonline.com/pp8/#!/9228/pr… @PNKampaktsis @AspasiaTzanii @DoulamisIlias @ACCinTouch

Delighted to share our paper on #biventricular #conversion after #Fontan completion. ✅Feasible ✅No mortality when elective ✅Can be performed after recruitment ▶️jtcvs.org/article/S0022-… @AATSHQ @AATSJournals @interactiveachd @BCH_HeartCenter @BostonChildrens @harvardmed

✅Exciting app about #congenital #heart #defects #chd by University of Padua! Thank you @AlviseGuariento for sharing!! ▶️ apps.apple.com/us/app/congeni…

Excited for this exciting opportunity for #collaboration and #networking

#Cardiotwitter, have you ever heard about @actioncardiac? ACTION is a group of young investigators created to establish international collaboration, already including a large group of cardiologists, cardiac surgeons, and cardiac anesthesiologists from all over the 🌎🌏🌍. Open 🧵